![Jenny Barnett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jenny Barnett
Amministratore Delegato presso Monument Therapeutics Ltd.
Posizioni attive di Jenny Barnett
Società | Posizione | Inizio | Fine |
---|---|---|---|
Monument Therapeutics Ltd.
![]() Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Amministratore Delegato | 01/01/2019 | - |
Storia della carriera di Jenny Barnett
Precedenti posizioni note di Jenny Barnett
Società | Posizione | Inizio | Fine |
---|---|---|---|
CAMBRIDGE COGNITION HOLDINGS PLC | Direttore Tecnico/Scientifico/R&S | - | 01/04/2022 |
Cambridge Cognition Ltd.
![]() Cambridge Cognition Ltd. Packaged SoftwareTechnology Services Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | 03/05/2013 |
Corporate Officer/Principal | 03/05/2013 | - |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Settori
Technology Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CAMBRIDGE COGNITION HOLDINGS PLC | Technology Services |
Aziende private | 2 |
---|---|
Cambridge Cognition Ltd.
![]() Cambridge Cognition Ltd. Packaged SoftwareTechnology Services Cambridge Cognition Ltd. operates as a neuroscience technology company delivering near-patient assessment solutions to improve the understanding, diagnosis and treatment of neurological and psychiatric disorders. It offers CANTAB Tests and Services, CANTAB mobile and CANTABeclipse. The company was founded in 2002 and is headquartered in Cambridge, GB. | Technology Services |
Monument Therapeutics Ltd.
![]() Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Monument Therapeutics Ltd. is a British UK-based biotechnology company that focuses on bringing precision medicine to neuroscience drug development. The company is based in Bottisham, UK, and was founded in 2019. The company was formed as a spin-out from Cognition and has a mission to use precision medicine to develop therapeutic products for patients with substantial central nervous system indications and significant unmet medical needs. Monument Tx has a well-balanced pipeline that includes two lead programs, and proprietary biomarkers developed by the team allow for precise selection of patients most likely to benefit from treatment. The therapeutic products under development are novel formulations utilizing well-characterized technology. Jenny Barnett has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Jenny Barnett
- Esperienza